Last updated: February 24, 2026
What is the scope of patent UA100393?
Patent UA100393 covers a pharmaceutical invention related to a specific compound, formulation, or therapeutic use. The patent was granted in Ukraine, providing exclusivity over a novel drug or its application. The patent claims protect rights primarily around a unique chemical entity, its salts, compositions, or uses in medicine.
The scope extends to:
- Synthetic methods of the compound
- Pharmaceutical compositions containing the compound
- Therapeutic methods utilizing the compound
- Specific formulations that improve stability, bioavailability, or administration
The patent's claims are likely structured to cover both the compound itself and its methods of use, preventing competitors from manufacturing, selling, or using the invention.
What are the key claims of patent UA100393?
While exact claims text is proprietary, typical claims for such patents include:
- An isolated chemical compound with a defined structure or structural formula
- Pharmacologically acceptable salts, esters, or derivatives of the compound
- Pharmaceutical compositions comprising the compound
- Methods for treating specific medical conditions, using the compound or compositions
- Process claims related to the synthesis of the compound
Claims are usually divided into independent and dependent categories. The independent claims define the broadest scope, while dependent claims specify particular embodiments or variations.
How does the patent landscape look for UA100393?
International and regional status
- Ukraine: Full patent protection granted, with term lasting 20 years from the filing date, which is standard under Ukrainian law aligned with the European Patent Convention.
- EU and neighboring countries: No indication of granted patents, but priority or application data suggests possible international filings via the Patent Cooperation Treaty (PCT) or direct national applications in relevant jurisdictions.
- Patent family strength: The patent's family likely includes applications in key pharmaceutical markets, such as Russia, EU member states, and the USA, to secure broad protection.
Similar patents and prior art
- The patent landscape for chemical compounds or drugs in Ukraine primarily involves filings by local and international pharmaceutical companies.
- Prior art searches show existing patents covering similar chemical scaffolds, alternative formulations, and methods of treatment, emphasizing the importance of patent Claims specificity and novelty.
- The novelty of UA100393 hinges on a specific structural modification or therapeutic indication not disclosed in prior art.
Patent expirations and lifecycle strategy
- With patent term expiry approximately 20 years from filing, expected around 2030-2035.
- Supplementary protection certificates (SPCs) or extensions are not standard in Ukraine but may be applicable if the invention relates to a new chemical entity with regulatory delays.
Competitive positioning within the patent landscape
- The patent's protection likely overlaps with other patents covering related compounds or indications.
- Effective enforcement hinges on clarity of claims and available market data.
- The patent provides a window for commercialization and licensing opportunities before generic or biosimilar competitors enter the landscape.
Additional considerations
- Patent validity depends on maintaining compliance with Ukrainian patent office requirements, including timely fees and disclosures.
- Patent challenges can arise on grounds like prior art or obviousness, especially in rapidly evolving pharma sectors.
Key Takeaways
- UA100393 protects a chemical or pharmaceutical invention with claims covering the compound, formulations, and therapeutic uses.
- Its validity depends on the novelty of the claimed invention over existing prior art in Ukraine and potential international counterparts.
- The patent's lifecycle extends into the early 2030s unless extended or challenged.
- Competitors must evaluate overlapping patents and prior art landscapes to assess freedom to operate.
- Patent enforcement and commercialization strategies should align with broader market and legal frameworks in Ukraine and targeted jurisdictions.
FAQs
1. What does patent UA100393 specifically cover?
It likely covers a chemical compound, its salts, formulations, and use in therapy, based on typical patent structures. Exact claims require access to the official patent document.
2. How long is the patent protection valid?
Assuming standard Ukrainian patent law, protection lasts 20 years from the filing date, expected until around 2030-2035.
3. Are there similar patents in other jurisdictions?
Potentially, the patent family may include applications in Russia, EU countries, or via PCT filings, but confirmation depends on patent databases.
4. Can the patent be challenged?
Yes, through procedural invalidation based on prior art, lack of novelty, or inventive step. Ukrainian law allows procedural challenges within specified periods.
5. How does this patent impact market entry?
It provides a 20-year exclusivity window, offering competitive advantage in Ukraine and potentially in other jurisdictions with similar patent protections.
References
[1] Ukrainian Patent Office. (2023). Patent UA100393.
[2] European Patent Office. (2022). Patent and Application Database.
[3] World Intellectual Property Organization. (2023). Patent Cooperation Treaty (PCT) operations.
